Skip to main content
Home
 
 
 
MENU
Home
Janssen’s COVID-19 Vaccine Status >

Janssen Global Main Menu

  • Our Company
    • About Us
    • Contact Us
    • Grants & Giving
    • News Center
    • Our Leaders
    • Patient Safety information
    • Products
    • Sustainability
    • Transparency
    • VISIT JANSSEN IN YOUR COUNTRY
  • Our Focus
    • Therapeutic Areas
    • Cardiovascular, Metabolism and Retina
    • Immunology
    • Infectious Diseases & Vaccines
    • Neuroscience
    • Oncology
    • Pulmonary Hypertension
    • Patient Engagement
  • Our Science
    • Our Response to COVID-19
    • Clinical Trials
    • Compassionate Use & Pre-Approval Access
    • R&D Data Science
    • Janssen Global Trial Finder
    • World Without Disease Accelerator
    • Janssen Clinical Innovation
    • Precision Medicine & Janssen Diagnostics

Our Stories List

Making a Splash for Disease Awareness
Global_Trial_Finder
Making a Splash for Disease Awareness
Looking Under the Hood for Green Chemistry Solutions
Global_Trial_Finder
Looking Under the Hood for Green Chemistry Solutions
  • RETURN TO HOME

Global Trial Finder

  • text size

My Saved Trials

Loading…
We will use the location information you provide to find the clinical trials taking place close to you in accordance with our Privacy Policy. We do not store this data.
8 Trials found in 171 locations
Filters Clear Filters
Find trials accepting male participants Find trials accepting female participants
Gender
Under 18 years old 18 years or older
Age
Distance Away (mi)(km)
Currently Recruiting

redo search as i move the map

x
50

Indicates 50+ sites in this region: click to zoom in.

10

Indicates 10+ sites in this region: click to zoom in.

5

Indicates < 10 sites in this region: click to zoom in.

Corresponds to list: click to see trial.

View Map Legend
Save for later
Trial Saved!

Find all your Saved trials at the top of this screen

1.
A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer
  • Adenocarcinoma
  • Prostate Cancer

city
distance

  • Male
  • 18+ years
  • Recruiting
Save for later
Trial Saved!

Find all your Saved trials at the top of this screen

2.
ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer (ARX517)
  • Prostate Cancer

city
distance

  • Male
  • 18+ years
  • Recruiting
Save for later
Trial Saved!

Find all your Saved trials at the top of this screen

3.
A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer
  • Prostate Cancer

city
distance

  • Male
  • 18+ years
  • Recruiting
Save for later
Trial Saved!

Find all your Saved trials at the top of this screen

4.
A Study of JNJ-78278343 in Combination With Either JNJ-63723283 (Cetrelimab), Taxane Chemotherapy, or Androgen Receptor Pathway Inhibitors for Metastatic Prostate Cancer
  • Metastatic Castration-resistant Prostate Neoplasms

city
distance

  • Male
  • 18+ years
  • Recruiting
Save for later
Trial Saved!

Find all your Saved trials at the top of this screen

5.
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
  • Cancer
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Leukemia, Myeloid, Acute
  • Lymphoma, Non-Hodgkin
  • Metastatic Castration-resistant Prostate Cancer (mCRPC)
  • Myelodysplastic Syndromes
  • Solid Tumor, Adult

city
distance

  • All
  • 18+ years
  • Enrolling by invitation
Save for later
Trial Saved!

Find all your Saved trials at the top of this screen

6.
A Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPC (LIBERTAS)
  • Metastatic Castrate-sensitive Prostate Cancer

city
distance

  • Male
  • 18+ years
  • Recruiting
Save for later
Trial Saved!

Find all your Saved trials at the top of this screen

7.
A Study of JNJ-87189401 Plus JNJ-78278343 for Advanced Prostate Cancer
  • Advanced Prostate Cancer

city
distance

  • Male
  • 18+ years
  • Recruiting
Save for later
Trial Saved!

Find all your Saved trials at the top of this screen

8.
A Study for the Participants With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated With Androgen Deprivation Therapy (ADT) Plus Apalutamide or Enzalutamide (ArtemisPRO)
  • Metastatic Hormone-sensitive Prostate Cancer

city
distance

  • Male
  • 18+ years
  • Recruiting
  • 25230 Duarte, United States
  • 25231 Chicago, United States
  • 25232 New Orleans, United States
  • 25233 Omaha, United States
  • 25234 New York, United States
  • 25235 Cleveland, United States
  • 25236 Salt Lake City, United States
  • 35409 Los Angeles, United States
  • 35410 San Francisco, United States
  • 35411 Atlanta, United States
  • 35412 Indianapolis, United States
  • 35413 Ann Arbor, United States
  • 35414 Saint Louis, United States
  • 35417 Seattle, United States
  • 22745 Lyon Cedex 8, France
  • 22746 Marseille, France
  • 22747 Villejuif, France
  • 22749 Rotterdam, Netherlands
  • 22750 Madrid, Spain
  • 22752 Málaga, Spain
  • 33286 Beijing, China
  • 33287 Chongqing, China
  • 33289 Wen Zhou Shi, China
  • 33290 Kashiwa, Japan
  • 33291 Yokohama, Japan
  • 33292 Amsterdam, Netherlands
  • 36627 Guang Zhou Shi, China
  • 26123 Sarasota, United States
  • 26124 Grand Rapids, United States
  • 26125 Macquarie University, Australia
  • 26126 Melbourne, Australia
  • 26127 Woolloongabba, Australia
  • 34431 Philadelphia, United States
  • 36694 Brooklyn, United States
  • 36695 Mineola, United States
  • 36696 Kurralta Park, Australia
  • 31463 Gent, Belgium
  • 31464 Lille, France
  • 31466 Nagoya-shi, Japan
  • 31467 Chisinau, Moldova
  • 31468 Gdansk, Poland
  • 31469 Krakow, Poland
  • 31470 Skorzewo, Poland
  • 31471 Kyiv, Ukraine
  • 34242 Tbilisi, Georgia
  • 34243 Tokyo, Japan
  • 36944 Athens, Greece
  • 36945 Kaohsiung City, Taiwan
  • 36946 Taichung, Taiwan
  • 36947 Tainan, Taiwan
  • 36948 Taipei City, Taiwan
  • 36949 Plymouth, United Kingdom
  • 26986 Basking Ridge, United States
  • 26987 Middletown, United States
  • 26988 Montvale, United States
  • 26989 Commack, United States
  • 26990 Harrison, United States
  • 26994 Uniondale, United States
  • 27005 Dallas, United States
  • 27050 Lubeck, Germany
  • 28016 Natal, Brazil
  • 34452 Fresno, United States
  • 34454 Santa Barbara, United States
  • 34455 Middleburg Heights, United States
  • 34456 Pittsburgh, United States
  • 34457 Germantown, United States
  • 34459 Norfolk, United States
  • 34462 Paris, France
  • 36699 Homewood, United States
  • 36700 Tucson, United States
  • 36701 Little Rock, United States
  • 36702 Lakewood, United States
  • 36703 Daytona Beach, United States
  • 36704 Chicago Ridge, United States
  • 36705 Joliet, United States
  • 36706 Greenwood, United States
  • 36707 Jeffersonville, United States
  • 36708 Silver Spring, United States
  • 36709 Towson, United States
  • 36710 Troy, United States
  • 36711 Syracuse, United States
  • 36712 Cincinnati, United States
  • 36713 Gahanna, United States
  • 36714 Tigard, United States
  • 36715 Bala-Cynwyd, United States
  • 36717 Nashville, United States
  • 36718 Austin, United States
  • 36720 Houston, United States
  • 36722 San Antonio, United States
  • 36723 Wichita Falls, United States
  • 36725 Roanoke, United States
  • 36726 Virginia Beach, United States
  • 36729 South Brisbane, Australia
  • 36730 Barretos, Brazil
  • 36731 Belo Horizonte, Brazil
  • 36732 Rio de Janeiro, Brazil
  • 36733 Salvador, Brazil
  • 36734 Santo André, Brazil
  • 36735 Sao Paulo, Brazil
  • 36736 Calgary, Canada
  • 36737 Halifax, Canada
  • 36738 Toronto, Canada
  • 36740 Quebec, Canada
  • 36741 Changchun, China
  • 36742 Chengdu, China
  • 36743 Guangzhou, China
  • 36744 Jinan, China
  • 36745 Ningbo, China
  • 36746 Shenyang, China
  • 36747 Wuhan, China
  • 36748 XI An, China
  • 36749 Bordeaux, France
  • 36751 Rennes, France
  • 36753 Aachen, Germany
  • 36754 Augsburg, Germany
  • 36755 Dresden, Germany
  • 36756 Koeln, Germany
  • 36757 Muenchen, Germany
  • 36758 Nuertingen, Germany
  • 36759 Würzburg, Germany
  • 36760 Chihuahua, Mexico
  • 36761 Durango, Mexico
  • 36762 Merida, Mexico
  • 36763 Queretaro, Mexico
  • 36764 Bydgoszcz, Poland
  • 36765 Koszalin, Poland
  • 36766 Warszawa, Poland
  • 36768 Wroclaw, Poland
  • 21307 Aurora, United States
  • 24532 Wels, Austria
  • 24533 Wien, Austria
  • 24534 Avignon, France
  • 24537 Brest, France
  • 24538 La Tronche, France
  • 24540 Nancy, France
  • 24541 Nimes, France
  • 24544 Pontoise, France
  • 24545 Quint-Fonsegrives, France
  • 24546 Saint-Grégoire, France
  • 24547 Suresnes, France
  • 24548 Toulouse cedex 9, France
  • 24551 Duisburg, Germany
  • 24552 Gladenbach, Germany
  • 24553 Hamburg, Germany
  • 24555 Muenster, Germany
  • 24556 Regensburg, Germany
  • 24559 Athina, Greece
  • 24561 Thessaloniki, Greece
  • 24563 Almería, Spain
  • 24564 Castellon, Spain
  • 24565 Cádiz, Spain
  • 24566 La Laguna, Spain
  • 24567 Lugo, Spain
  • 24569 Santiago de Compostela, Spain
  • 24570 Valencia, Spain
  • 24571 Berkshire, United Kingdom
  • 24572 Devon, United Kingdom
  • 24573 Guildford, United Kingdom
  • 24574 Oldham, United Kingdom
  • 24575 Scunthorpe, United Kingdom
  • 24576 Worthing, United Kingdom
  • 27820 Strasbourg, France
  • 27822 London, United Kingdom
  • 33905 Mainz, Germany
  • 33907 Heraklion, Greece
  • 33908 Patras, Greece
  • 33909 A Coruna, Spain
  • 33911 Cornwall, United Kingdom
  • 33912 Dorchester, United Kingdom
  • 33914 Taunton, United Kingdom
  • 36779 Dierdorf, Germany

Footer

  • PRIVACY POLICY
  • LEGAL NOTICE
  • COOKIE POLICY
  • COOKIE SETTINGS
  • CAREERS
  • NEWS CENTER
  • DO NOT SELL MY PERSONAL INFORMATION

Footer Social

Find Janssen Global on:

twitter youtube linkedin

Janssen Global Policy text

©Johnson & Johnson Innovative Medicine. All Rights Reserved. This website is hosted and operated by Johnson & Johnson Innovative Medicine, which is solely responsible for its content. This website is intended for a global audience.